Market Research

Today, we will adventure down a particularly head-spinning rabbit hole that is the intersection between artificial intelligence and psychedelics. These two novel tools have one fascinating caveat in common: no one fully understands them and what their implications for the future of humanity are. So naturally, we decided to ask AI what it thinks about psychedelics. For those who are familiar with the scientific evidence that is perpetuating the psychedelic industry, it is easy to say that psychedelics should be legal. However, it is important to keep in mind that much of the world is still wary of these peculiar…

Psychedelic legalization in the US first took place in 2020 when Oregon voted to legalize psilocybin use. Just three years later, an influx of other states are looking into the benefits of psychedelics and working to increase access. Psychedelic legalization efforts are spreading across the country. In the next ten years, there will be a huge increase in access to these medicines. No two states are taking the same approach. The different platforms being given to psychedelic medicines are based on the individual needs and beliefs of each state.  The Types of Psychedelic Legal Reform Several routes can be taken…

The release of quarterly financial reports over the past few weeks is providing some much-needed insight into the state of the industry. It is becoming apparent which companies are rising to the top and which are struggling to stay afloat. The recent release of Braxia Scientific’s financial statement raises some questions about its ability to do the former. A press release from the company bragged about positive revenue growth from its ketamine clinics. Braxia did report a 26% increase in treatment volume and a 27% increase in revenue from its clinics from the previous year. However, the whole picture is…

Psychedelic science is in its infancy stage, so there is a lot that is still unknown. One of these unknowns is the safety and efficacy of taking a psychedelic medicine while on a Selective Serotonin Reuptake Inhibitor (SSRI). This is a question that is often discussed. There has always been concern and interest about the interaction between these two drug classes, but little is known about it. The answer to this question has major implications in the psychedelic drug development space because a lot of the people who could benefit from psychedelic-assisted therapy are currently taking an SSRI. Since they…

Several US states have psychedelic-favored legislation underway, but none more than California. The state is pioneering psychedelic reform with two major initiatives in the works.  Though a handful of cities have decriminalized various psychedelic compounds, they remain illegal in the Golden State. However, that may be on the brink of change. There are two major initiatives attempting to permanently shift the legal landscape of psychedelics in California.  If both Senate Bill 58 and TREAT California become law, California will be taking a two-pronged approach to increase access to psychedelic medicines. Both initiatives are quite different than what we’ve seen in…